We will utilize genome sequencing to identify the genetic causes of primary and acquired resistance of Merkel cell carcinomas to immunotherapy.
|Effective start/end date||7/1/19 → 6/30/21|
- National Comprehensive Cancer Network (Agmt 6/24/19)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.